Owens and Minor Inc. (NYSE: OMI), Richmond, Va., a global healthcare solutions provider, reported sales for its fiscal 2023 second quarter were $2.56 billion, up 2.5% from the prior-year period.
Net income for the quarter was $28.2 million, down 1.4% from the prior-year period.
Patient Direct revenue was $633 million, up 10.5% from the prior-year period. Products & Healthcare Services revenue was $1.93 billion, flat compared to the prior-year period.
Owens and Minor also reported sales for its first six months of 2023 were $5.09 billion, up 3.7% from the prior year. Net income for the first six months was $52.7 million, down 22.4% from the prior-year period.
“The second quarter of 2023 shows a continuation of our Patient Direct segment’s exceptional performance, with another quarter of double-digit growth and strength across the major categories that we serve,” said Edward A. Pesicka, CEO, Owens & Minor. “Our Products and Healthcare Services segment demonstrated resilience during the quarter with sales growth in the Medical Distribution division, but the segment experienced continued revenue headwinds in our higher margin Global Products division.”